Literature DB >> 22257936

Minicircle DNA electrotransfer for efficient tissue-targeted gene delivery.

S Chabot1, J Orio, M Schmeer, M Schleef, M Golzio, J Teissié.   

Abstract

A major issue for successful human gene therapy or genetic vaccination is a safe high-transgene expression level. Plasmid-based (non-viral) physical methods of gene transfer offered attracting approaches but their low efficiencies have limited their use in human pre-clinical trials. One of the limits appears to be the size of the plasmid that must be transferred across the cell membrane to the nucleus for its processing. In the present work to enhance gene transfer and expression, we evaluated a new generation of DNA vector; the minicircle, combined with the electropulsation technique. Minicircle is a doubled-stranded circular DNA with reduced size as it is devoid of bacterial sequences. We showed that electrotransferred minicircle encoding green fluorescent protein had higher in vitro transfection level compared with full-length plasmid. We demonstrated that minicircle great efficiency was not because of cellular toxicity decrease but was correlated to more efficient vector uptake by cells. Vector electrotransfection was operated in vivo and, using fluorescence imaging, minicircle electrotransfer was shown to enhance the efficiency and duration of tissue-targeted gene delivery and expression. By combining powerful expression and delivery systems, we have provided a valuable method for new approaches in gene therapy and genetic vaccination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257936     DOI: 10.1038/gt.2011.215

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  21 in total

1.  Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA.

Authors:  Jaemin Kim; Vanessa K P Oliveira; Ami Yamamoto; Rita C R Perlingeiro
Journal:  Stem Cell Res       Date:  2017-07-12       Impact factor: 2.020

Review 2.  Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Taruna Anand; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

3.  Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.

Authors:  Dennis Kobelt; Jutta Aumann; Manuel Schmidt; Burghardt Wittig; Iduna Fichtner; Diana Behrens; Margit Lemm; Greta Freundt; Peter M Schlag; Wolfgang Walther
Journal:  Mol Oncol       Date:  2014-01-18       Impact factor: 6.603

4.  Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver.

Authors:  Hiu Man Viecelli; Richard P Harbottle; Suet Ping Wong; Andrea Schlegel; Marinee K Chuah; Thierry VandenDriessche; Cary O Harding; Beat Thöny
Journal:  Hepatology       Date:  2014-07-29       Impact factor: 17.425

5.  Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors.

Authors:  R Monjezi; C Miskey; T Gogishvili; M Schleef; M Schmeer; H Einsele; Z Ivics; M Hudecek
Journal:  Leukemia       Date:  2016-06-24       Impact factor: 11.528

Review 6.  Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

Authors:  Arunima Panda; Narasimman Gurusamy; Sheeja Rajasingh; Hannah-Kaye Carter; Edwin L Thomas; Johnson Rajasingh
Journal:  Differentiation       Date:  2020-01-10       Impact factor: 3.880

7.  Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection.

Authors:  Christine I Wooddell; David B Rozema; Markus Hossbach; Matthias John; Holly L Hamilton; Qili Chu; Julia O Hegge; Jason J Klein; Darren H Wakefield; Claudia E Oropeza; Jochen Deckert; Ingo Roehl; Kerstin Jahn-Hofmann; Philipp Hadwiger; Hans-Peter Vornlocher; Alan McLachlan; David L Lewis
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

8.  Electric field-assisted delivery of photofrin to human breast carcinoma cells.

Authors:  Joanna Wezgowiec; Maria B Derylo; Justin Teissie; Julie Orio; Marie-Pierre Rols; Julita Kulbacka; Jolanta Saczko; Malgorzata Kotulska
Journal:  J Membr Biol       Date:  2013-04-02       Impact factor: 1.843

Review 9.  Nonviral methods for inducing pluripotency to cells.

Authors:  Ryan O'Doherty; Udo Greiser; Wenxin Wang
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

10.  A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles.

Authors:  Hyoju Yi; Youngkyun Kim; Juryun Kim; Hyerin Jung; Yeri Alice Rim; Seung Min Jung; Sung-Hwan Park; Ji Hyeon Ju
Journal:  Sci Rep       Date:  2014-08-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.